AgingResearch.NewsJoin free

Intensive glycemic control

Intensive glycemic control has been studied in 8 papers since 2019: 2 trials in people, 6 reviews; 2 in the past year. The newest story, Nov 9, 2026: “Type 2 diabetes and obesity linked to faster brain aging”.

Intervention

8 papers study it8 findingsUpdated

1 new paper in 30 daysSee all 8 papers on intensive glycemic control

At a glance

The findings reach people, from one lab or study. 2 independent labs in 1 country.

“intensive glycemic control was not associated with significant differences in BAG trajectories compared with standard treatment (p > 0.05)”
Type 2 Diabetes and Obesity in Relation to Accelerated Brain Aging: Evidence from 12 Cohorts and 2 Randomized Clinical TrialsAHA Scientific Sessions 2026 abstract2026doi:10.1161/circ.154.suppl_1.6410

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

  • 2 independent labs in 1 country
  • Human trial2

What did studies of intensive glycemic control find?

4

Studies of intensive glycemic control measured 4 outcomes, among them brain age gap, diabetic retinopathy and hypoglycemia.

Brain age gap

no changein humans1

1 study

  1. Intensive glycemic control showed no clear effect on brain age gap in humans (ACCORD-MIND; compared with standard treatment).

    “intensive glycemic control was not associated with significant differences in BAG trajectories compared with standard treatment (p > 0.05)”

    Human trialACCORD-MIND; compared with standard treatmentbrain

    Type 2 diabetes and obesity linked to faster brain aging

    AHA Scientific Sessions 2026 abstract

More on Brain age gap

Diabetic retinopathy

downin reviews1

1 study

  1. Intensive glycemic control decreases diabetic retinopathy.

    “intensive glycemic treatment improves DR”

    Review

    Diabetes and the Retina: The Role of Medical Treatment

    Journal of diabetes

More on Diabetic retinopathy

Hypoglycemia

upin humans1

1 study

  1. Intensive glycemic control induces hypoglycemia in humans.

    “intensive glycemic control involving antidiabetic medications, while beneficial for reducing diabetic complications, can often precipitate hypoglycemic events”

    Review

    Advancing Diabetes Management and Glycemic Control While Exploring CagriSema's Impact on Obesity Management

    Cardiology in review

More on Hypoglycemia

Mortality

no changein humans1HR 0.96

1 study

  1. Intensive glycemic control showed no clear effect on mortality in humans (older or frail adults with type 2 diabetes) (HR 0.96, 95% CI 0.90-1.03).

    “No difference was noted in all-cause mortality with intensive control (pooled hazard ratio 0.96, 95% confidence interval 0.90-1.03)”

    Reviewolder or frail adults with type 2 diabetes

    Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies

    Expert review of endocrinology & metabolism

What is intensive glycemic control linked with?

3

Studies link intensive glycemic control with 3 measures: microvascular complications, macrovascular complications and hypoglycemia.

Microvascular complications

downin humans1downin reviews1

2 studies

  1. Intensive glycemic control lowers the risk of microvascular complications in humans (older or frail adults with type 2 diabetes) (0.73, 95% CI 0.68-0.79).

    “Intensive control was associated reductions in microvascular (0.73, 0.68-0.79) and macrovascular complications (0.84, 0.79-0.89).”

    Reviewolder or frail adults with type 2 diabetes

    Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies

    Expert review of endocrinology & metabolism

  2. Intensive glycemic control lowers the risk of microvascular complications (type 2 diabetes mellitus).

    “Although intensive glycaemic control has been shown to effectively reduce the risk of microvascular complications in T2DM”

    Reviewtype 2 diabetes mellitus

    Physiological monitoring of the complex multimorbid heart failure patient - diabetes and monitoring glucose control

    European heart journal supplements : journal of the European Society of Cardiology

More on Microvascular complications

Macrovascular complications

downin humans1

1 study

  1. Intensive glycemic control lowers the risk of macrovascular complications in humans (older or frail adults with type 2 diabetes) (0.84, 95% CI 0.79-0.89).

    “macrovascular complications (0.84, 0.79-0.89)”

    Reviewolder or frail adults with type 2 diabetes

    Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies

    Expert review of endocrinology & metabolism

More on Macrovascular complications

Hypoglycemia

upin humans1

1 study

  1. Intensive glycemic control raises the risk of hypoglycemia in humans (older or frail adults with type 2 diabetes) (2.45, 95% CI 2.22-2.72).

    “risk of severe hypoglycemia increased (2.45, 2.22-2.72)”

    Reviewolder or frail adults with type 2 diabetes

    Intensive glycemic control and macrovascular, microvascular, hypoglycemia complications and mortality in older (age ≥60years) or frail adults with type 2 diabetes: a systematic review and meta-analysis from randomized controlled trial and observation studies

    Expert review of endocrinology & metabolism

More on Hypoglycemia

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 12 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Type 2 diabetes and obesity linked to faster brain aging

Across 12 cohorts, type 2 diabetes was linked to a brain age gap 1.73 years higher than in people without diabetes.Across 12 cohorts, type 2 diabetes was linked to a brain age gap 1.73 years higher than in people without diabetes.

Meta-analysis · 47,994 peopleType 2 diabetes
Paper

Related